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Chronic pancreatitisebilitating disease with high morbidity and mortality. Treatment is mostly
supportive, and until now there are no clinically useful strategies for anti-inﬂammatory therapy. Although
omega-3 polyunsaturated fatty acids (n-3 PUFA) are known to have anti-inﬂammatory effects, the utility of
these fatty acids in the alleviation of pancreatitis remained to be investigated. The aim of this study was to
examine the effect of n-3 PUFA on both acute and chronic pancreatitis in a well-controlled experimental
system. We used the fat-1 transgenic mouse model, characterized by endogenously increased tissue levels of
n-3 PUFA, and their wild-type littermates to examine the effect of n-3 PUFA on both acute and chronic
cerulein-induced pancreatitis. Disease activity and inﬂammatory status were assessed by both histology and
molecular methods. In acute pancreatitis, fat-1 mice showed a trend towards decreased necrosis and
signiﬁcantly reduced levels of plasma IL-6 levels as well as reduced neutrophil inﬁltration in the lung. In
chronic pancreatitis there was less pancreatic ﬁbrosis and collagen content accompanied by decreased
pancreatic stellate cell activation in the fat-1 animals with increased n-3 PUFA tissue levels as compared to
wild-type littermates with high levels of omega-6 (n-6) PUFA in their tissues. Our data provide evidence for a
reduction of systemic inﬂammation in acute pancreatitis and of tissue ﬁbrosis in chronic pancreatitis by
increasing the tissue content of omega-3 polyunsaturated fatty acids. These results suggest a beneﬁcial
potential for n-3 PUFA supplementation in acute and particularly chronic pancreatitis.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Acute pancreatitis (AP) is characterized by severe abdominal pain
and oedematous or necrotic organ changes that can lead to a severe
systemic inﬂammation with severe morbidity in 20% of cases and
approximately 4% mortality [1]. There are no speciﬁc therapies for
acute pancreatitis. Medical management is aimed at the control of
symptoms, the prevention of severe complications, and possibly
endoscopic stone removal if common bile duct stones are present or
suspected [2]. In acute pancreatitis organ damage is usually initiated
by autodigestion of the pancreas. This process begins in the
pancreatic acinar cell with intracellular proteolytic activation of
pancreatic enzymes leading to the initiation of autodigestion. This istal 149-13th Street, Room 4433
: +1 617 726 6144.
ll rights reserved.followed by a massive inﬂammatory reaction with inﬁltration of
neutrophils and macrophages. While the role of these inﬂammatory
cells in the removal of necrotic material is important, there is also
evidence that the massive inﬂammatory reaction exacerbates damage
by secretion of pro-inﬂammatory cytokines with subsequent release
of proteases and reactive oxygen species [1]. Indeed, several
antioxidants were shown in experimental models to protect from
tissue damage in acute pancreatitis (AP) [3]. In addition there is
experimental evidence that COX-2 inhibition [4–8] as well as genetic
deletion of COX-2 [9] can protect from tissue damage in AP. This
suggests involvement of the pro-inﬂammatory arachidonic acid
cascade in AP.
Chronic pancreatitis (CP) affects 5.6 to 24.2 million people in the
United States [10,11] and can be a debilitating chronic medical
condition characterized by bouts of severe pain and progressive
organ dysfunction with endocrine and exocrine organ insufﬁciency.
Chronic pancreatitis can be due to genetic factors, and correlations
with mutations in PRSS1 and PRSS2 as well as SPINK1 and CFTR are
well characterized by now [11]. The disease is often associated with
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management is total abstinence. So far, the only medical treatment
options for chronic pancreatitis (CP) are control of symptoms (pain),
the treatment of the resulting endocrine (diabetes mellitus) and
exocrine pancreas insufﬁciency as well as alleviation of bile duct
stenosis arising from chronic inﬂammatory and ﬁbrotic changes in
the head of the pancreas [11]. There are different theories to explain
the pathogenesis of chronic pancreatitis, including pancreatic duct
damage by obstruction or primary autoimmune or inﬂammatory
events [10], followed by multiple bouts of acute inﬂammation and
necrotic changes of the pancreas with progressive organ ﬁbrosis
[11]. Common consequence of all these pathological processes is the
chronic damage of pancreatic tissue with persisting presence of
ﬁbrogenic pancreatic stellate cells that secrete collagen and
cytokines [12–15]. Approaches used so far to alleviate the course
of CP [16] include immunomodulation [17,18], Cox-2 inhibitors [19],
and antioxidants [20].
Omega-3 polyunsaturated fatty acids (n-3 PUFA) have been
implicated in inﬂammation dampening [21]. Recent research has
identiﬁed potent anti-inﬂammatory mediators derived from n-3 PUFA
and elucidated the mechanisms of their action [22]. The n-3 PUFA
derived mediators are known to play a key role in the resolution of
inﬂammation and therefore termed resolvins and protectins [23]. Our
previous results in the fat-1 mouse model showed that an increased
tissue status of n-3 PUFA led to formation of resolvins and protectins
and to protection from acute DSS-induced colitis [24]. Recent studies
have implicated a role of n-3 PUFA in the dampening of acute
pancreatic inﬂammation [25–28].
The cerulein-induced pancreatitis is an experimental mouse
model for human acute and chronic pancreatitis characterized by
histological changes (inﬂammatory inﬁltrate, oedema, cell necrosis),
increased serum amylase and lipase, release of pro-inﬂammatory
cytokines (TNF-α, IL-1β), and activation of trypsinogen in acinar
cells [29].
The study presented here was designed to examine the effect of
an endogenously increased n-3 PUFA status on the induction and
development of acute and chronic cerulein-induced pancreatitis in
fat-1 mice versus wild-type (wt) control animals. These transgenic
mice express a Caenorhabditis elegans desaturase, leading to the
formation of endogenously high levels of n-3 PUFA from n-6 PUFA,
changing the n-6/n-3 PUFA ratio from values around 30/1 to ratios
of approximately 1–5/1 [30]. In contrast to feeding studies
supplementing n-3 PUFA, the fat-1 model eliminates confounding
factors of diet (content of trace elements, ﬁbres, antioxidants etc.)
that could have signiﬁcant effects on the course of pancreatitis
itself.
2. Materials and methods
2.1. Mice
Transgenic fat-1 micewere generated andmaintained as described
previously [30]. The heterozygous female offspring from several
breeding pairs was used for induction of acute pancreatitis, while the
male offspring from these matings was used for induction of chronic
pancreatitis.
2.2. PUFA analysis
Fatty acid proﬁles were analyzed using gas chromatography as
described previously [31].
2.3. Induction of pancreatitis
Cerulein was purchased from Research plus Inc. NJ. For acute
pancreatitis (AP), mice received 12 hourly intraperitoneal injections of50 μg/kg bodyweight cerulein in 200 μl saline or only 200 μl saline
(control group). Animals were sacriﬁced 1 h after the last injection
(Fig. 1A). Chronic pancreatitis (CP) was induced by 6 hourly intraper-
itoneal injections of 50 μg/kg cerulein (Sigma) in saline or only saline;
three days a week, for 6 weeks. One week after the last injectionweek
all mice were sacriﬁced (Fig. 3A). Mice were anesthetized with
isoﬂurane and killed by cardiopuncture to maximize blood yield. Parts
of the pancreas and the lungs were snap-frozen in liquid nitrogen and
stored at −70 °C, while other parts were ﬁxed in 10% buffered formalin
and embedded in parafﬁn.
2.4. Evaluation of pancreatitis severity
Pancreatitis was evaluated by measurement of serum amylase
and lipase activity and by histopathological assessment of
morphological changes. Hematoxylin-eosin stainings were per-
formed of pancreatic sections and lung sections. For acute pan-
creatitis, an experienced pathologist blinded to the experimental
treatment examined oedema, acinar cell necrosis, and inﬂamma-
tory cell inﬁltration. For chronic pancreatitis lobular atrophy, acinar
atrophy, ﬁbrosis and inﬂammation were examined by a blinded
observer.
2.5. Immunohistochemistry
Fresh pancreatic or lung tissue was ﬁxed in 10% neutral buffered
formalin overnight, followed by automated processing and embed-
ding in parafﬁn. MPO-staining was performed on formalin-ﬁxed
parafﬁn embedded tissue using the avidin-biotin-peroxidase com-
plex technique. A rabbit polyclonal antibody to Myeloperoxidase
RTU (Abcam) was used as primary antibody in 1:100 dilutions. The
sections were incubated overnight at 4 °C. As secondary antibody a
biotinylated Goat anti rabbit IgG (Vector Laboratories) was used in a
1:250 dilution. The tissue was counterstained with hematoxylin,
negative controls were performed without the primary antibody.
For α-SMA staining the slides were exposed to a 1:25 diluted
(equals 8 μl/ml) anti-α-SMA antibody (Thermo-Fischer-Scientiﬁc)
for 10 min at room temperature. After washing with PBS, the
primary anti-α-SMA antibody was detected using an Alexa ﬂuor
595 antibody. Stainings were quantiﬁed by counting the number of
α-SMA-positive cells in 1–3 HPFs per mouse by two different
blinded observers, positive cells located in or near blood vessel
walls were ignored, and the mean value of these counts was used
for further analysis. Data are expressed as the number of α-SMA-
positive cells per 100 pancreatic cells. For visualization of pancreatic
cell nuclei, cells were co-stained with DAPI (4,6-diamine-2-pheny-
lindole dihydrochloride) in an aqueous dilution of 1:10.000 for 5–
10 min.
2.6. Quantiﬁcation of intrapancreatic collagen
Parafﬁn sections were de-waxed and hydrated and stained in a
solution of 0.1% Sirius red in saturated picric acid for 45 min at room
temperature, as described previously [32]. Slices were then rinsed
with acidiﬁed water and afterwards in 100% ethanol. The sections
were then cleared in Xylene and subsequently mounted in mounting
medium. The total amount of collagen stained on each section was
calculated in a blinded fashion as follows and as described
previously [33]. In the ﬁrst step, pancreas was distinguished from
the background according to a difference in light density, and a
measurement of the total pancreatic tissue area was performed. In
the second step, the amount of collagen (stained in red) was
measured and was ﬁnally expressed as a percentage of the total
pancreatic surface. The mean of the values in 3 ﬁelds per mouse was
used for further analysis.
Fig. 1. Acute pancreatitis in fat-1 and wild-type mice. (A) Acute pancreatitis was induced by 12 hourly intraperitoneal injections of cerulein. (B) Fat-1 treated mice are less susceptible
to injury caused by the cerulein-induced pancreatitis. As compared to saline-injected wild-type (upper left panel) and fat-1 (upper right panel) control animals, the pancreas of wild-
type mice injected with cerulein shows acinar cell destruction and necrosis (lower left). These histological signs of acute pancreatitis are reduced in fat-1 mice treated with cerulein
(lower right). Hematoxylin-eosin stains (200×) are shown for the different groups. (C) Expression of IL-1βmRNA, measured by RT-PCR, in mice with acute pancreatitis, n=3 for both
groups. ⁎pb0.05 versus wild-type mice with acute pancreatitis. (D) Pancreatic necrosis score in mice with acute pancreatitis. Differences were not signiﬁcant.
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Total RNA was isolated from whole pancreas tissue using RNeasy
mini kit (Qiagen) following the manufacturer's instructions and RT-
PCR performed as described previously [24,34].
2.8. Determination of MPO-activity
Myeloperoxidase (MPO) activity as a reﬂection of neutrophil
sequestration within the lung was assessed as described previously
[33]. Brieﬂy, lung tissue was homogenized in 50 mM potassium
phosphate (pH 6), containing 0.5 g/dl centrimonium bromide,
followed by 3 freeze-thaw circles and sonication. We then incubated
the samples for 2 h at 60 °C and centrifuged for 20 min. The
supernatant was added to 50 mM potassium phosphate (pH 6)
containing 0.167 mg/ml o-dianisidine dihydrochloride and 0.0005%hydrogen peroxide and absorbancewasmeasured at 460 nm for 3min
every 30 s.
2.9. IL-6-ELISA
For evaluation of the systemic inﬂammatory activity, serum IL-6
was measured inwt and fat-1 treated and control mice. The ELISAwas
purchased from eBioscience and performed according to the manu-
facturer's protocol.
2.10. Statistical analysis
All results are presented as mean±SEM, except where stated
otherwise. Student's t test was used to evaluate the difference
between two groups. RT-PCR was analyzed by using the 2ΔCt
method. Statistical signiﬁcance was accepted at the level of pb0.05
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calculations.
3. Results
3.1. Fatty acid proﬁles in the pancreas
There was a signiﬁcant difference in the n-3 and n-6 PUFA tissue
content between pancreas tissue from untreatedwt and fat-1 animals,
with a AA/EPA+DHA ratio in fat-1 mice of 0.1 (with predominantly EPA
present) as compared to a very high ratio of 61.3 in wild-type mice.
These differences led us to our study of pancreatitis in this model.Fig. 2. Signs of systemic inﬂammation in acute pancreatitis. (A) Serum IL-6 levels in wild
pancreatitis (fat-1 AP, n=5). ⁎pb0.05 compared to wild-type mice with acute pancreatitis. (
with acute pancreatitis (fat-1 AP, n=5) as compared to wild-type animals with acute
Myeloperoxidase (MPO) antibody staining in lung tissue (400× magniﬁcation), reﬂecting n
marked neutrophil inﬁltration (left panel). In comparison, lung tissue of a fat-1 mouse with3.2. Increased n-3 PUFA tissue content reduces necrosis in acute
pancreatitis
We treated fat-1 and wild-type mice with repeated cerulein
injections over one day to induce acute pancreatitis (Fig. 1A). All
animals developed severe lipasemia and amylasemia with no
signiﬁcant differences between the fat-1 and the wt animals.
Histological scoring of pancreas tissue revealed a trend towards
decreased pancreatic necrosis in the fat-1 mice (Fig. 1B and D). In RT-
PCR analysis of pancreatic tissuewe found decreased expression of the
pro-inﬂammatory cytokine IL-1β in fat-1 mice (Fig. 1C). There were
no signiﬁcant differences in the mRNA expression levels of TGF-β and-type mice with acute pancreatitis (wt AP, n=6) compared to fat-1 mice with acute
B) Myeloperoxidase activity in lung tissue demonstrating lower levels in fat-1 animals
pancreatitis (wt AP, n=4), ⁎pb0.05 versus wt animals with acute pancreatitis. (C)
eutrophil inﬁltration. Tissue from a wild-type mouse with acute pancreatitis showed
acute pancreatitis showed less inﬁltration (right panel).
Fig. 3. Chronic pancreatitis and collagen content in wt and fat-1 mice. (A) Chronic pancreatitis was induced over seven weeks with six intraperitoneal injections of cerulein every
second day for six weeks. Mice were then sacriﬁced one week later. (B) Serum amylase levels of wt animals with chronic pancreatitis (wt CP, n=8), and fat-1 animals with chronic
pancreatitis (fat-1 CP, n=9). Differences were not signiﬁcant. (C) Quantiﬁcation of collagen as area of collagen per total pancreatic tissue in percent. Wild-type animals with chronic
pancreatitis (wt CP, n=9) and fat-1 animals with chronic pancreatitis (fat-1 CP, n=13) are shown. ⁎pb0.05 versus wild-type animals with chronic pancreatitis. (D) Pancreas tissue
samples of wild-type (upper left) and fat-1 (upper right) controls and of wild-type (lower left) and fat-1 (lower right) mice with chronic pancreatitis stained with Sirius Red for the
visualization of collagen. Magniﬁcation is 200×.
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RT-PCR analysis was limited by the small amounts of tissue material.
3.3. Reduced systemic inﬂammation in fat-1 mice with acute pancreatitis
To test for the systemic inﬂammatory reaction in acute pancrea-
titis, we examined IL-6 in the plasma which is regarded as a sensitive
parameter for the severity of acute pancreatitis. IL-6 levels were
signiﬁcantly lower in fat-1 mice with AP as compared to wt animals
with AP (pb0.05) (Fig. 2A). A similar change was observed in the
myeloperoxidase (MPO) activity in lung tissue, showing signiﬁcantly
lowerMPO-activity in fat-1micewith AP as compared towtmicewithAP (Fig. 2B). Identifying neutrophils in the lung by staining for MPO
supported these data (Fig. 2C).
3.4. Decreased ﬁbrosis in fat-1 mice with chronic pancreatitis
The decreased activity of AP in fat-1 mice suggested the possibility
of a beneﬁcial effect on chronic inﬂammation dampening in this
context. We therefore studied chronic cerulein-induced pancreatitis
(Fig. 3A) in fat-1 mice to examine the effects of the endogenously
increased n-3 PUFA tissue status on organ atrophy and ﬁbrosis. Fat-1
mice with chronic pancreatitis lost less body weight than their wt
littermates (27.0 g±0.4 versus 25.5 g±0.9). In addition there were
Fig. 4. IL-6 and pancreatic stellate cells in chronic pancreatitis. (A) Level of IL-6 in the serum of wtmice with chronic pancreatitis (wt CP, n=6) and fat-1mice with chronic pancreatitis
(fat-1 CP, n=4). The difference was not signiﬁcant (p=0.13). (B) Quantiﬁcation of activated pancreatic stellate cells (PSC) in pancreatic tissue of wild-type (wt CP, n=6) and fat-1 mice
(fat-1 CP n=3) with chronic pancreatitis. ⁎pb0.05 versus wt CP. (C) Pancreas tissue double-stained with DAPI and anti-α-SMA antibody for detection of activated PSC inwild-type and
fat-1 animals with chronic pancreatitis and respective controls. Magniﬁcation is 200×.
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compared to wt mice (Fig. 3B), but both of these differences were not
signiﬁcant. There was, however, a signiﬁcant difference in the amount
of ﬁbrosis as evidenced by Sirius red staining for collagen content of
pancreatic tissue. Image analysis of representative samples demon-
strated a lower tissue collagen content in pancreatic tissue from fat-1
mice with CP as compared to the collagen content in wt mice with CP
(pb0.05) (Fig. 3C and D).
3.5. Increased n-3 PUFA tissue content decreased IL-6 and pancreatic
stellate cell activation in chronic pancreatitis
As an indication for the decreased inﬂammatory activity plasma
levels of IL-6 were also lower in fat-1 mice with CP as compared to
wild-type mice (Fig. 4A). Recent research has implicated pancreatic
stellate cells (PSC), myoﬁbroblast-like cells found in the exocrine
pancreas, as potent producers of interleukins in the context of
pancreatic inﬂammation [35]. Pancreatic stellate cells also contribute
to excess synthesis of extracellular matrix, leading to ﬁbrotic organchanges commonly associatedwith CP and alsowith pancreatic cancer
[12].We examined the presence of activated pancreatic stellate cells in
fat-1 and wt mice with cerulein-induced CP and found a signiﬁcant
difference. Staining with an antibody against alpha smooth muscle
actin (α-SMA), a sensitive method to demonstrate activated pancrea-
tic stellate cells, showed a lower content of activated PSC in fat-1 mice
with CP than in wild-type animals with CP (Fig. 4B and C).
4. Discussion
The results presented here show that an increased n-3 PUFA tissue
status in the pancreas can alleviate acute as well as chronic
inﬂammatory changes in the organ. Particularly noteworthy in this
context is the reduction of ﬁbrosis in chronic pancreatitis, as ﬁbrosis is
important for morbidity and prognosis of the disease.
In this study we observed a trend towards decreased necrotic
changes in pancreas tissue with high n-3 PUFA tissue content. A
decreased necrosis in fat-1 mice with AP could contribute to the
decreased acute inﬂammation by reducing the rupture and leakage of
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reducing the ensuing inﬂammatory tissue reactions. There was a
lower expression of IL-1β observed in the fat-1 mice with AP. On a
systemic level, inﬂammation dampening was evident by lower IL-6
serum levels in fat-1 mice with AP as compared to their wt littermates
with AP. Indeed, IL-6 levels have been implicated as important
prognostic parameter in human pancreatitis [36,37]. Our data
demonstrate that the increased n-3 PUFA tissue content also lowers
neutrophil inﬁltration in the lung and thus showa lowered pulmonary
inﬂammatory reaction as a further sign of decreased systemic
inﬂammation and multiorgan involvement. These results are consis-
tent with previous studies showing beneﬁcial effects of n-3 PUFA on
acute pancreatitis [25–27].
The dampening of acute pancreatitis episodes could be the basis for
the alleviated course of CP in fat-1 animals. Our data demonstrate
signiﬁcantly less ﬁbrotic changes in fat-1 mice with CP as compared to
their wt littermates with the disease. Most hypotheses for the
development of chronic pancreatitis favour a repeated hit mechanism
involving many bouts of acute pancreatitis, leading to the changes of
chronic pancreatitis that are associated with signiﬁcant morbidity and
high healthcare expenditure in the western world. In this study we
demonstrate for the ﬁrst time that there could be a role for n-3 PUFA in
the reduction of the tissue damage typical for chronic pancreatitis. This
was reﬂected in a signiﬁcantly lower collagen content in fat-1 mice
with CP as compared towtmicewith CP, aswell as in a signiﬁcantly less
intensive activation of pancreatic stellate cells, which have an
important role in the pathogenesis of pancreatic ﬁbrosis and are also
involved in the pancreatic inﬂammatory reaction [12].
The lipid data in fat-1 mice demonstrate signiﬁcantly decreased
levels of particularly AA in the pancreas of fat-1 animals. Interestingly,
the most important n-3 PUFA present in pancreas tissues of these
animals is eicosapentaenoic acid (EPA), also a 20-carbon PUFA that is
metabolized to lipid mediators by the same enzymes metabolizing AA
[38,39]. EPA is also precursor of resolvin E1 and resolvin E2, substances
with potent anti-inﬂammatory effects that were described and
characterized recently [22,40,41]. Therefore the decreased inﬂamma-
tory activity observed here could be a result of a shift from AA-derived
lipid mediators to EPA-derived lipid mediators. Particularly the EPA and
DHA derived resolvins have been implicated in the processes involved
in inﬂammation resolution [23,42]. Clearance of inﬂammatory cells and
resolution of inﬂammation could thus be signiﬁcantly promoted by the
increased presence of n-3 PUFA in fat-1 mice. Thus, protection from
pancreatic ﬁbrosis could be a consequence of enhanced resolution that
is mediated by lipid mediators formed from EPA in the context of
repeated bouts of acute pancreatitis. Future studies are needed to
address this question, as the sparse pancreas tissue available from the
mice did not allow detailed analyses of lipid mediators in this study.
Taken together, the results presented here show that an increased
n-3 PUFA tissue status in the pancreas decreases the systemic
inﬂammatory response in acute pancreatitis and reduce ﬁbrotic
changes in chronic pancreatitis. These data now need veriﬁcation in
other animal models as well as in the context of human disease.
Together with the previous animal [25–27], as well as human studies
[43,44] examining acute pancreatitis and n-3 PUFA supplementation,
our data support a potential beneﬁt for n-3 PUFA supplementation
particularly in chronic pancreatitis.
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